Bioisosteric similarity of drugs in virtual screening by Hutter, Michael C & Krier, Markus
POSTER PRESENTATION Open Access
Bioisosteric similarity of drugs in virtual screening
Michael C Hutter
*, Markus Krier
From 5th German Conference on Cheminformatics: 23. CIC-Workshop
Goslar, Germany. 8-10 November 2009
Choosing compounds for screening is difficult problem
due the vast chemical space. The question is thus which
compounds are most likely to be hits. The comparison
of drugs that all target the same enzyme, however,
shows reoccurring chemical modification throughout all
therapeutic categories. These so-called bioisosteric repla-
cements [1] comprise simple exchanges of terminal
atoms as well as more complex structural modifications,
such as ring closures or rearrangements of larger frag-
ments. To detect and evaluate all kinds of replacements
we have designed an approach that adopts the algorith-
mic concept used to assess the homology of amino acid
sequences to chemical molecules. The mutual exchange
frequencies between distinct atom types are expressed
in a substitution matrix [2]. Likewise, pair-wise align-
ment between the molecules is constructed using
dynamic programming [3], with the compounds being
represented as unique SMILES. To obtain the actual
exchange frequencies, we refined an initial matrix based
on observed chemical replacements [4] by collecting the
generated alignments of 1353 drugs from 33 therapeutic
categories in an automated procedure. To compute the
mutual bioisosteric similarity between two molecules a
specific function has been derived that makes use of the
alignment [5].
To asses the suitability of this bioisosteric similarity
for virtual screening, we compared the recovery of
known drugs against the background of other sub-
stances. The majority of drugs possess a higher similar-
ity within the same class than compared to substances
from the ZINC [6] or the Prous Science Drugs of the
Future database [7]. Likewise, drugs for the same target
are usually recovered at higher values of similarities
than compared to other methods based on most com-
mon substructure and fingerprint approaches. Moreover,
nondrugs without any pharmaceutical function exhibit
considerably lower similarities than actual drugs.
Furthermore, this bioisosteric similarity can be used to
express the chemical diversity within a given compound
class. We found that e.g. inhibitors of the HIV Reverse
Transcriptase are more divers than Angiotensin-II
Antagonists and Tetracycline Antibiotics.
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